Skip to Content

16-1-01 QUILT-88: Open-label, Randomized, Comparative Phase 2 Study of Combination Immunotherapy plus Standard-of-Care Chemotherapy versus Standard-of-Care Chemotherapy for First and Second Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer (QUILT-88)


Clinical Trial Details >>

Principal Investigator(s)
Heidi McKean, MD

Clinical Trial Categories

  • Pancreatic Cancer
Medical Oncology Research Coordinators at 605-322-3295


  • Avera Cancer Institute at Sioux Falls
    1000 E. 23rd Street
    Sioux Falls, SD 57105
    Main: 605-322-3000
    Alternate: 800-657-4377

Moving Health Forward

Avera is a health ministry rooted in the Gospel. Our mission is to make a positive impact in the lives and health of persons and communities by providing quality services guided by Christian values.

© 2022 Avera Health, Sioux Falls, SD. All Rights Reserved.